Aprea Therapeutics, Inc. (APRE)
- Previous Close
4.1800 - Open
4.1800 - Bid --
- Ask --
- Day's Range
3.8598 - 4.1800 - 52 Week Range
2.1500 - 8.8470 - Volume
19,545 - Avg. Volume
21,201 - Market Cap (intraday)
21.184M - Beta (5Y Monthly) 1.90
- PE Ratio (TTM)
-- - EPS (TTM)
-2.9300 - Earnings Date Nov 7, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.67
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.
www.aprea.comRecent News: APRE
View More
Performance Overview: APRE
Trailing total returns as of 10/23/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: APRE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: APRE
View MoreValuation Measures
Market Cap
22.71M
Enterprise Value
-6.08M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.89
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-30.25%
Return on Equity (ttm)
-50.11%
Revenue (ttm)
1.28M
Net Income Avi to Common (ttm)
-12.93M
Diluted EPS (ttm)
-2.9300
Balance Sheet and Cash Flow
Total Cash (mrq)
28.69M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-9.36M
Research Analysis: APRE
View MoreCompany Insights: APRE
APRE does not have Company Insights
Research Reports: APRE
View MoreDaily – Vickers Top Buyers & Sellers for 10/18/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 10/17/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 10/16/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.